European white paper: oropharyngeal dysphagia in head and neck cancer
- PDF / 1,941,720 Bytes
- 40 Pages / 595.276 x 790.866 pts Page_size
- 108 Downloads / 209 Views
HOW I DO IT
European white paper: oropharyngeal dysphagia in head and neck cancer Laura W. J. Baijens1,2 · Margaret Walshe3 · Leena‑Maija Aaltonen4 · Christoph Arens5 · Reinie Cordier6,7 · Patrick Cras8 · Lise Crevier‑Buchman9 · Chris Curtis10 · Wojciech Golusinski11 · Roganie Govender12 · Jesper Grau Eriksen13 · Kevin Hansen14 · Kate Heathcote15 · Markus M. Hess16,17 · Sefik Hosal18 · Jens Peter Klussmann14 · C. René Leemans19,20 · Denise MacCarthy21 · Beatrice Manduchi3 · Jean‑Paul Marie22 · Reza Nouraei23 · Claire Parkes24 · Christina Pflug17 · Walmari Pilz1,25 · Julie Regan3 · Nathalie Rommel26 · Antonio Schindler27 · Annemie M. W. J. Schols28 · Renee Speyer6,7,29,30 · Giovanni Succo31,32 · Irene Wessel33 · Anna C. H. Willemsen2,28,34 · Taner Yilmaz35 · Pere Clavé36,37 Received: 27 February 2020 / Accepted: 17 November 2020 © The Author(s) 2020
Abstract Purpose To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe. Methods Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensusbased position statements, and expert opinion. Results Twenty-four sections on HNC-specific OD topics. Conclusion This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers. Keywords Head and neck cancer · Dysphagia · White paper · Deglutition · Swallowing
Introduction The state of the art and minimum standards of oropharyngeal dysphagia (OD) care will vary by country across Europe and will depend on the setting of the medical care [acute hospital, Endorsed by the European Society for Swallowing Disorders (ESSD), the Confederation of European Otorhinolaryngology Head and Neck Surgery (CEORL-HNS), the European Head and Neck Society (EHNS), the Union of the European Phoniatricians (UEP), and the European Laryngological Society (ELS). * Laura W. J. Baijens [email protected] Extended author information available on the last page of the article
rehabilitation unit, community nursing home, speech-andlanguage pathologist (SLP) first-li
Data Loading...
